文献速递免疫规划卫生政策与健康促进

美国2022年13-17岁青少年疫苗接种覆盖率——国家青少年免疫调查

Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2022.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2023-08-25

CDC分析2022年国家青少年免疫调查中16,043名13-17岁青少年的数据,评估疫苗接种覆盖率。出生队列分析显示,2008年出生青少年在14岁前的接种覆盖率仍落后于较早出生队列,且随社会人口学因素和医疗可及性而异;2009年出生青少年在13岁前的覆盖率与COVID-19大流行前相似。13-17岁青少年总体2022年覆盖率与2021年无差异,但医疗补助保险者的HPV疫苗系列启动率下降。

要点

  • 2008年出生青少年14岁前接种覆盖率仍落后于较早出生队列。
  • 2009年出生青少年13岁前覆盖率与大流行前相似。
  • 医疗补助保险者HPV疫苗系列启动率下降。

核心结论

  • 2008年出生青少年14岁前接种覆盖率仍落后于较早出生队列,且随社会人口学因素和医疗可及性而异;2009年出生青少年13岁前覆盖率与大流行前相似。
  • 13-17岁青少年2022年总体接种覆盖率与2021年无差异,但医疗补助保险者的HPV疫苗系列启动率下降。

研究设计与样本

  • CDC分析2022年国家青少年免疫调查(National Immunization Survey-Teen)中16,043名13-17岁青少年的数据。
  • 采用出生队列分析评估13岁前和14岁前接种覆盖率趋势,并采用横断面分析评估13-17岁青少年覆盖率。

主要发现

  • 2022年,2008年出生青少年14岁前接种覆盖率继续落后于较早出生队列,且随社会人口学因素和医疗可及性而异。
  • 2009年出生青少年13岁前接种覆盖率与COVID-19大流行前估计值相似。
  • 13-17岁青少年2022年接种覆盖率与2021年无差异。
  • 医疗补助保险者的HPV疫苗系列启动率下降。
  • ≥1剂破伤风、白喉、无细胞百日咳疫苗和≥1剂脑膜炎球菌结合疫苗覆盖率较高且稳定(约90%)。

关键数值与推荐

  • ≥1剂破伤风、白喉、无细胞百日咳疫苗和≥1剂脑膜炎球菌结合疫苗覆盖率约90%。

临床怎么用

  • 作者建议:提供者应审查青少年疫苗接种记录,尤其是2008年出生者和符合儿童疫苗计划(Vaccines for Children program)资格的人群,以确保青少年及时接种所有推荐疫苗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Three vaccines are routinely recommended for adolescents to prevent pertussis, meningococcal disease, and cancers caused by human papillomavirus (HPV). CDC analyzed data from the 2022 National Immunization Survey-Teen for 16,043 adolescents aged 13-17 years to assess vaccination coverage. Birth cohort analyses were conducted to assess trends in vaccination coverage by age 13 years (i.e., before the 13th birthday) and by age 14 years (i.e., before the 14th birthday) among adolescents who were due for routine vaccination before and during the COVID-19 pandemic. Cross-sectional analysis was used to assess coverage estimates among adolescents aged 13-17 years. In 2022, vaccination coverage by age 14 years among adolescents born in 2008 continued to lag that of earlier birth cohorts and varied by sociodemographic factors and access to health care compared with coverage among earlier birth cohorts. Vaccination coverage by age 13 years among adolescents born in 2009 was similar to coverage estimates obtained before the COVID-19 pandemic. Among all adolescents aged 13-17 years, 2022 vaccination coverage levels did not differ from 2021 levels; however, initiation of the HPV vaccination series decreased among those who were insured by Medicaid. Coverage with ≥1 dose of tetanus, diphtheria, and acellular pertussis vaccine and ≥1 dose meningococcal conjugate vaccine was high and stable (around 90%). Providers should review adolescent vaccination records, especially among those born in 2008 and those in populations eligible for the Vaccines for Children program, to ensure adolescents are up to date with all recommended vaccines.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Pingali C, Yankey D, Elam-Evans LD, et al. Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2022. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37616185. doi:10.15585/mmwr.mm7234a3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。